HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) All Versions of this Article: cmr.2008.828v1 7/3/93    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Calvo-Romero, J. M. Articles by Lima-Rodríguez, E. M. Search for Related Content PubMed PubMed Citation Articles by Calvo-Romero, J. M. Articles by Lima-Rodríguez, E. M.

Anticardiolipin Antibodies in Patients With Type 2 Diabetes Mellitus

Internal Medicine Service, Hospital Ciudad de Coria, Coria (Cáceres), Spain

Esther María Lima-Rodríguez, MD

Family Medicine, Montehermoso (Cáceres), Spain

Corresponding Author: José María Calvo-Romero, MD, Internal Medicine Service, Hospital Ciudad de Coria, Cervantes 75, 10800 Coria (Cáceres), Spain, Email:jm.calvo{at}hotmail.es

Abstract

Background: There is controversy about an increased prevalence of antiphospholipid antibodies in diabetics patients, and the possible implications are little known.

Methods: We prospectively studied all consecutive outpatients with type 2 diabetes mellitus (DM) attended in an Internal Medicine office. IgM and IgG anticardiolipin antibodies (ACA) were determined by standardized enzyme-linked immunoassay.

Results: Fifty-six patients were included. Only one patient (1.8%) had a titer of IgM ACA higher than 15 MPL units and no patient had a titer of IgG ACA higher than 15 GPL units. Six patients (10.7%) had low (4–15 MPL units) IgM ACA titers and 18 patients (32.1%) had low (4–15 GPL units) IgG ACA titers. There were no differences in the frequencies of a low IgM or IgG ACA titer or in the means of IgM and IgG ACA titers in patients with complicated and uncomplicated DM, with and without cardiovascular disease, with and without nephropathy or with and without retinopathy.

Conclusions: Moderate-high ACA titers must be exceptional in patients with type 2 DM. Low ACA titers may occur in patients with type 2 DM. These low titers do not seem to be associated with complicated DM, cardiovascular disease, nephropathy or retinopathy.

Key Words: Anticardiolipin • Antiphospholipid • Diabetes mellitus